4.19 USD
↘ 0.17 (3.88%)LIVE (AS OF 11:02 AM EDT)
Enlivex Ltd. Ordinary Shares
ENLVNASDAQ • USD
Market: OPEN
ENLV is currently priced at $4.19. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ENLV is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jul 23, 2026.
Open?$4.36
High?$5.26
Low?$4.20
Prev. Close?$4.36
Volume?30.4K
Avg. Volume?320.0K
VWAP?$4.74
Rel. Volume?0.09x
Bid / Ask
Bid?$3.61 × 100
Ask?$4.56 × 100
Spread?$0.95
Midpoint?$4.09
Valuation & Ratios
Market Cap?73.4M
Shares Out?16.8M
Float?32.2M
Float %?13.3%
P/E Ratio?N/A
P/B Ratio?2.07
EPS?-$0.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?6.64Safe
Confidence?33%Very Low
Short InterestModerate
Short % of Float?4.70%Low
Short Interest?1.5M
Days to Cover?4.0
Free Float32.2M
Avg Daily Volume376.3K
Settlement Date2026-06-30
Financial Health
Current Ratio?1.85Adequate
Quick Ratio?1.85Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.07CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.7%WEAK▾
S&P7
ROA?-20.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$67.7M
Fundamentals ratios updated end of day